Novel drug discovery system for cancer stem cells in human squamous cell carcinoma of the esophagus

DOI Web Site PubMed 被引用文献7件 参考文献16件 オープンアクセス

書誌事項

公開日
2013-12-30
資源種別
journal article
DOI
  • 10.3892/or.2013.2952
公開者
Spandidos Publications

この論文をさがす

説明

Cancer stem cells (CSCs) have been identified in several tumor tissues. Since CSCs are resistant to cancer therapies, including chemotherapy and radiation therapy, and can even remain after therapies, tumor tissue often regrows and relapses. Thus, identification of CSCs and treatment targeting CSCs are required to treat tumor tissues. Reportedly, a fluorescent vector consisting of fluorescein ZsGreen fused to the carboxyl-terminal region of ornithine decarboxylase (cODC) was used to detect CSCs or therapy-resistant cancer cells in tumor tissues of the brain, pancreas and liver. Cells transfected with the fluorescent vector can express a fluorescein fused to cODC and become fluorescent only when the fusion protein is accumulated. In the present study, CSCs or therapy-resistant cancer cells were identified with the fluorescent vector in esophageal squamous cell carcinoma. The use of this fluorescent vector in drug screening enabled the detection of three drugs, AKT inhibitor XI, ERK inhibitor II and JAK inhibitor I, which target malignant CSCs.

収録刊行物

  • Oncology Reports

    Oncology Reports 31 (3), 1133-1138, 2013-12-30

    Spandidos Publications

被引用文献 (7)*注記

もっと見る

参考文献 (16)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ